Cargando…

Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies

BACKGROUND: Medication targeting by community pharmacists may assess medical history of patients for recommendation of clinical services through review of their prescription history. Previous studies have implemented medication targeting to identify patients eligible for vaccine recommendations. Tar...

Descripción completa

Detalles Bibliográficos
Autores principales: LaFleur, Grace E., Azzi, Andrew G., Schimmel, Scott M., Howard, Mitchell S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715457/
https://www.ncbi.nlm.nih.gov/pubmed/36566098
http://dx.doi.org/10.1016/j.sapharm.2022.11.013
_version_ 1784842454673915904
author LaFleur, Grace E.
Azzi, Andrew G.
Schimmel, Scott M.
Howard, Mitchell S.
author_facet LaFleur, Grace E.
Azzi, Andrew G.
Schimmel, Scott M.
Howard, Mitchell S.
author_sort LaFleur, Grace E.
collection PubMed
description BACKGROUND: Medication targeting by community pharmacists may assess medical history of patients for recommendation of clinical services through review of their prescription history. Previous studies have implemented medication targeting to identify patients eligible for vaccine recommendations. Targeting of immunosuppressing medications may impact the rate of third primary doses of COVID-19 vaccine administered to immunocompromised patients. OBJECTIVES: The primary objective was to determine the impact of medication targeting on the rate of third primary doses of COVID-19 vaccine given to immunocompromised patients. METHODS: This observational, retrospective cohort study occurred within one division of a large community pharmacy chain. Included patients were greater than 18 years of age with record of at least one immunosuppressing medication dispensed one year prior to study enrollment and 2 primary COVID-19 vaccine doses in the pharmacy dispensing software. An intervention for pharmacist recommendation of a third primary dose of COVID-19 vaccine was automatically loaded into their prescription profiles. The proportion of patients with completed interventions and confirmation of third dose administration was collected with demographic characteristics. RESULTS: The pharmacy dispensing software identified 1670 interventions through medication targeting, though 69 interventions met criteria for study inclusion. Baseline characteristics of the included population were a mean age of 51.8 years of primarily female sex (69.6%) and Caucasian race (78.3%). Third primary COVID-19 vaccine dose administration and completed pharmacist recommendation was recorded for 2 (2.9%) patients. CONCLUSION: Medication targeting identified immunocompromised patients for the recommendation of a third primary dose of COVID-19 vaccine. Improved specification for targeting of dosing regimen and route of administration may result in greater accuracy of appropriate recommendations identified.
format Online
Article
Text
id pubmed-9715457
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-97154572022-12-02 Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies LaFleur, Grace E. Azzi, Andrew G. Schimmel, Scott M. Howard, Mitchell S. Res Social Adm Pharm Article BACKGROUND: Medication targeting by community pharmacists may assess medical history of patients for recommendation of clinical services through review of their prescription history. Previous studies have implemented medication targeting to identify patients eligible for vaccine recommendations. Targeting of immunosuppressing medications may impact the rate of third primary doses of COVID-19 vaccine administered to immunocompromised patients. OBJECTIVES: The primary objective was to determine the impact of medication targeting on the rate of third primary doses of COVID-19 vaccine given to immunocompromised patients. METHODS: This observational, retrospective cohort study occurred within one division of a large community pharmacy chain. Included patients were greater than 18 years of age with record of at least one immunosuppressing medication dispensed one year prior to study enrollment and 2 primary COVID-19 vaccine doses in the pharmacy dispensing software. An intervention for pharmacist recommendation of a third primary dose of COVID-19 vaccine was automatically loaded into their prescription profiles. The proportion of patients with completed interventions and confirmation of third dose administration was collected with demographic characteristics. RESULTS: The pharmacy dispensing software identified 1670 interventions through medication targeting, though 69 interventions met criteria for study inclusion. Baseline characteristics of the included population were a mean age of 51.8 years of primarily female sex (69.6%) and Caucasian race (78.3%). Third primary COVID-19 vaccine dose administration and completed pharmacist recommendation was recorded for 2 (2.9%) patients. CONCLUSION: Medication targeting identified immunocompromised patients for the recommendation of a third primary dose of COVID-19 vaccine. Improved specification for targeting of dosing regimen and route of administration may result in greater accuracy of appropriate recommendations identified. Elsevier Inc. 2023-04 2022-12-02 /pmc/articles/PMC9715457/ /pubmed/36566098 http://dx.doi.org/10.1016/j.sapharm.2022.11.013 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
LaFleur, Grace E.
Azzi, Andrew G.
Schimmel, Scott M.
Howard, Mitchell S.
Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies
title Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies
title_full Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies
title_fullStr Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies
title_full_unstemmed Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies
title_short Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies
title_sort technology targeting immunocompromised patients for covid-19 vaccine in community pharmacies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715457/
https://www.ncbi.nlm.nih.gov/pubmed/36566098
http://dx.doi.org/10.1016/j.sapharm.2022.11.013
work_keys_str_mv AT lafleurgracee technologytargetingimmunocompromisedpatientsforcovid19vaccineincommunitypharmacies
AT azziandrewg technologytargetingimmunocompromisedpatientsforcovid19vaccineincommunitypharmacies
AT schimmelscottm technologytargetingimmunocompromisedpatientsforcovid19vaccineincommunitypharmacies
AT howardmitchells technologytargetingimmunocompromisedpatientsforcovid19vaccineincommunitypharmacies